Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

(S)he said what?!?
Novo Nordisk continues to make headway in the development of Degludec and DegludecPlus, the company’s two new “next-generation” insulins. The company recently announced...
Curious about Medtronic’s Enlite sensor? Nikos Filippou discusses his experience with the new product.
Amylin and JDRF will be looking into the possibility of combining Symlin and insulin into one injection. Earlier this month, Amylin and JDRF entered a partnership to...
We were heartened this year by World Diabetes Day, which officially recognizes the growing epidemics of diabetes, diabetes complications, and obesity. Every year on...
Our top takeaways from the European Association for the Study of Diabetes meeting in Stockholm, and The Obesity Society meeting in San Diego.
Although no one ever said insulin pump management was easy, we’re very happy that new tools are emerging that can make pumping easier and better. We have often wondered...
June and July have been very busy months in the diabetes world...
Testing blood sugar levels day in and day out isn't always fun for kids. But what if they were rewarded with points for each test that was within range and also for...
Kerri Morrone Sparling gives her take on the pros and cons of CGM.
Bayer presented an interactive overview of its CGM product in development, which has a number of features that the company says will make it easier to use than current...
In a recent study, Novo Nordisk's next-generation basal insulin degludec was found to cause less hypoglycemia than Lantus. In early May, Novo Nordisk announced the...
Powerhouse AADE Educator of the Year Elaine Massaro emphasizes the importance of behavior change and how to do it.
We had a great time at AADE learning more about what DexCom has in the works—primarily this relates to work toward FDA approval for its fourth-generation continuous...
Puzzled by the recent FDA decisions? Dr. Sanjay Kaul discusses the regulatory environment for diabetes and obesity medications.
Dan Hurley gives a passionate assessment of the rise of diabetes in his book, Diabetes Rising .
The FDA just approved Medtronic’s latest insulin pump, called the MiniMed Paradigm REAL-Time Revel System – this is Medtronic’s first new pump platform to be approved in...
Life without insulin? Impossible, right? Thea Cooper and Arthur Ainsberg’s Breakthrough recounts the remarkable story of insulin’s discovery.
As we wrote in New Now Next in diaTribe #24, Insulet and DexCom submitted their combined insulin pump-continuous glucose monitor (CGM) device for FDA approval during an...
An evolutionary step for Paradigm pumpers – see Dana Lewis’s take on Medtronic’s new pump/CGM integrated platform the Paradigm REAL-Time Revel system.

Pages